To develop a comprehensive intervention policy for future management of cervical cancer in
China and Mongolia, it is essential to review the prevalence of human papillomavirus (HPV) …

Cervical cancer is ranked the first or second most common cancer in women of low-and
middle-income countries (LMICs) in Asia. Cervical cancer is almost exclusively caused by …

Human papillomavirus (HPV)-related cancers are a major worldwide public health concern.
Virtually all cervical cancer is HPV related, with 70% caused by HPV16 and-18. Variable …

In May, 2013, a cluster of adverse events suspected to be linked to HPV vaccination were
reported in the Japanese media, prompting the Japanese Government to suspend proactive …

Cervical cancer, human papillomavirus (HPV), and HPV vaccines Page 1 Cervical cancer,
human papillomavirus (HPV), and HPV vaccines Key points for policy-makers and health …

The human papillomavirus (HPV) vaccine is the first vaccine developed specifically targeting
the prevention of cervical cancer. For more than 15 years, China has expedited a series of …

In Japan, the morbidity and mortality of cervical cancer have recently been on the rise.
According to the Japanese Center for Cancer Control and Information Services …

The incidence rate and mortality rate of cervical cancer have steadily increased in young
women in China. Therefore, it is critical to improve HPV vaccination rates, particularly for the …

We have expressed our concern about HPV vaccination coverage in Japan remaining
below 1%, which will result in an increase in vaccine-targeted HPV infection rates and …

The current global novel coronavirus disease 2019 (COVID-19) pandemic threatens to
derail the uptake of human papillomavirus (HPV) vaccination in low-and lower-middle …